NICE Call for Evidence

Closed 9 Jan 2015

Opened 1 Dec 2014


In recent years, the health and social care system in England has undergone substantial change. The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and Arm’s Length Bodies.

In this new system, the Department has the key stewardship and assurance function designed to ensure that the new system and so the multiple new and reformed bodies within it, have the appropriate functions and are performing to a high standard.

To perform this stewardship function, the Department is putting in place Triennial Reviews of all of its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Public Bodies (ANDPBs), Executive Agencies and Special Health Authorities. As an Executive Non-Departmental Public Body (ENDPB) the National Institute for Health and Care Excellence (NICE) is subject to review in 2014-15.

The programme of reviews uses the approach developed by the Cabinet Office as part of their work on Public Bodies Reform.


Why We Are Consulting

As noted above, this review is part of a wider programme that the Department of Health has developed as part of its stewardship and assurance function. The review will have two main stages:


  • The first is to provide a robust challenge of the continuing need for NICE both in terms of the functions it performs, and the way in which these are delivered.


  • If it is agreed that NICE should retain its current function and utilise the same delivery model, the second stage of the review will then consider its performance, capability and governance, as well as considering opportunities for efficiencies.


This call for evidence seeks views from respondents to assist its consideration of both of the above stages.

On 20th November 2014, George Freeman (Minister for Life Sciences) announced the Innovative Medicines and Medical Technology Review to consider how our healthcare and regulatory systems can best respond and adapt to the new landscape of innovation.  This review will start in 2015 and will report recommendations to the new Government.  It covers only one element of NICE’s role; how NICE approves new technologies, including drugs, for use in the NHS in the short and longer term. It does not consider other facets of the role of NICE, such as quality standards and evidence services.

The Triennial Review of NICE will not be considering the detail of how NICE approves new technologies.  Any evidence submitted on this element of NICE’s work will be forwarded to the more specialised review for their consideration.  Please bear this in mind when submitting your responses.


  • Voluntary groups
  • Community groups
  • Charities
  • Civil society
  • Advocacy or support organisations
  • GPs
  • Nurses
  • Health visitors
  • Clinicians
  • Managers
  • Commissioners
  • Directors of Public Health
  • Pharmacists
  • Doctors
  • Midwives
  • Healthcare scientists
  • Paramedics
  • Dentists
  • Art therapists
  • Dramatherapists
  • Music therapists
  • Chiropodists/ podiatrists
  • Dieticians
  • Occupational therapists
  • Orthotists
  • Orthopists
  • Prosthetists
  • Physiotherapists
  • Diagnostic radiographers
  • Therapeutic radiographers
  • Speech and language therapists
  • Childcare providers
  • Allied Health Professionals
  • Care-Givers
  • Ophthalmic Practitioners
  • Responsible Officers
  • Foundation Trusts
  • NHS Commissioning Board
  • Tribunal Service
  • Clinical Commissioning Groups
  • Regulatory body
  • Academic/ Professional institution
  • Employer representatives
  • Employee representatives
  • Trade union
  • Deaneries
  • Higher Education institutions
  • Royal Colleges
  • Local authority
  • Social care provider
  • Directors of Adult Social Care Services
  • Members of the public
  • Patients
  • Patients
  • Carers
  • Service users
  • Retailers
  • Suppliers
  • Information providers
  • Information professionals
  • Informatics professionals
  • PCT Cluster CEs
  • NHS Trust CEs
  • SHA Cluster CEs
  • Directors of PH
  • Local Authority CEs
  • Businesses
  • Public Health Organisations
  • Academics
  • Members of the Public


  • Nutrition
  • Children's health and development
  • Physical health
  • Health inequalities
  • Infectious disease
  • Vascular disease
  • Obesity
  • Environment
  • Sexual health
  • Alcohol misuse
  • Drug misuse
  • Public health
  • Health protection
  • Health improvement
  • Immunisation
  • Smoking
  • Public mental health
  • Tobacco
  • Physical activity
  • Public Health England
  • Health premium
  • Well-being
  • NHS Health Checks
  • Screening
  • Prevention
  • Oral public health
  • Health Protection Agency
  • Childcare
  • Health and Social Care Act 2012
  • Primary care
  • Mental health
  • End of life care
  • Maternity services
  • GP consortia
  • Adult social care
  • Carers
  • Dementia
  • Personal health budgets
  • IT
  • Informatics
  • Innovation
  • Education
  • Continuing Professional Development
  • Training
  • Health and well-being boards
  • Funding
  • Commissioning
  • Accountability
  • Transition
  • Health scrutiny
  • NHS Commissioning Board
  • Clinical Governance
  • Performers Lists
  • Complaints
  • Feedback